Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Mirum Pharmaceuticals stock
Learn how to easily invest in Mirum Pharmaceuticals stock.
Mirum Pharmaceuticals Inc is a biotechnology business based in the US. Mirum Pharmaceuticals shares (MIRM) are listed on the NASDAQ and all prices are listed in US Dollars. Mirum Pharmaceuticals employs 171 staff and has a trailing 12-month revenue of around $38.5 million.
How to buy shares in Mirum Pharmaceuticals
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – MIRM – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Mirum Pharmaceuticals stock price (NASDAQ: MIRM)Use our graph to track the performance of MIRM stocks over time.
Mirum Pharmaceuticals shares at a glance
|Latest market close||$21.37|
|52-week range||$12.82 - $30.55|
|50-day moving average||$24.32|
|200-day moving average||$22.27|
|Wall St. target price||$57.71|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-2.29|
Buy Mirum Pharmaceuticals shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Mirum Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Mirum Pharmaceuticals price performance over time
|1 week (2022-09-29)||1.81%|
|1 month (2022-09-06)||-15.16%|
|3 months (2022-07-06)||-1.75%|
|6 months (2022-04-05)||-11.84%|
|1 year (2021-10-06)||22.60%|
|2 years (2020-10-06)||14.65%|
|3 years (2019-10-04)||103.72%|
|5 years (2017-10-02)||N/A|
Mirum Pharmaceuticals financials
|Revenue TTM||$38.5 million|
|Gross profit TTM||$17.2 million|
|Return on assets TTM||-35%|
|Return on equity TTM||-51.44%|
|Market capitalisation||$772.2 million|
TTM: trailing 12 months
Mirum Pharmaceuticals share dividends
We're not expecting Mirum Pharmaceuticals to pay a dividend over the next 12 months.
Mirum Pharmaceuticals share price volatility
Over the last 12 months, Mirum Pharmaceuticals's shares have ranged in value from as little as $12.82 up to $30.545. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Mirum Pharmaceuticals's is 1.4305. This would suggest that Mirum Pharmaceuticals's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Mirum Pharmaceuticals overview
Mirum Pharmaceuticals, Inc. , a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the treatment of Alagille syndrome and biliary atresia disease. It also develops Volixibat drug for treatment of intrahepatic cholestasis of pregnancy and primary sclerosing cholangitis. Mirum Pharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Foster City, California. .
Mirum Pharmaceuticals in the news
Mirum Pharmaceuticals to Present LIVMARLI® (maralixibat) Analyses and Host a Scientific Symposium at NASPGHAN 2022 Annual Meeting
In spite of Mirum Pharmaceuticals, Inc.'s recent pullback, insiders still gained about US$56k after buying earlier this year.
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Frequently asked questionsWhat percentage of Mirum Pharmaceuticals is owned by insiders or institutions?
Currently 4.121% of Mirum Pharmaceuticals shares are held by insiders and 80.594% by institutions. How many people work for Mirum Pharmaceuticals?
Latest data suggests 171 work at Mirum Pharmaceuticals. When does the fiscal year end for Mirum Pharmaceuticals?
Mirum Pharmaceuticals's fiscal year ends in December. Where is Mirum Pharmaceuticals based?
Mirum Pharmaceuticals's address is: 950 Tower Lane, Foster City, CA, United States, 94404 What is Mirum Pharmaceuticals's ISIN number?
Mirum Pharmaceuticals's international securities identification number is: US6047491013 What is Mirum Pharmaceuticals's CUSIP number?
Mirum Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 604749101
More guides on Finder
How to buy YanGuFang International Group (YGF) stock when it goes public
Everything we know about the YanGuFang International Group IPO, plus information on how to buy in.
What are the FAANG stocks and how do you invest in them?
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
How to buy soccer stocks
A simple guide to buying stocks in your favorite European soccer team.
How to buy Juventus stock
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
How to buy AS Roma stock
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
How to buy Borussia Dortmund stock
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
How to buy Lead Real Estate Co. (LRE) stock when it goes public
Everything we know about the Lead Real Estate Co. IPO, plus information on how to buy in.
How to buy Third Harmonic Bio (THRD) stock
Everything we know about the Third Harmonic Bio IPO, plus information on how to buy in.
How to buy LINKBANCORP (LNKB) stock
Everything we know about the LINKBANCORP IPO, plus information on how to buy in.
Here are the stocks that benefit from inflation, as well as industries to keep an eye on to reduce the impacts of inflation on your portfolio.
Ask an Expert